Pluto Bioinformatics

GSE125864: Analysis of the genomic landscape in ALK+ NSCLC patients identifies novel aberrations associated with clinical outcomes

Bulk RNA sequencing

Expression data of primary and metastasic tissues from ALK+ NSCLC patients (Anaplastic lymphoma kinase fusion positive non-small cell lung carcinoma) SOURCE: Gerald Batist (gerald.batist@mcgill.ca) - Jewish General Hospital